Article
Phenotypes of Metabolic Dysfunction-Associated Steatotic Liver Disease-Associated Hepatocellular Carcinoma.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association - 1 Sept 2024
Rivera-Esteban Jesús, Muñoz-Martínez Sergio, Higuera Mónica, Sena Elena, Bermúdez-Ramos María, Bañares Juan, Martínez-Gomez María, Cusidó M Serra, Jiménez-Masip Alba, Francque Sven M, Tacke Frank, Minguez Beatriz, Pericàs Juan M
Abstract excerpt
Hepatocellular carcinoma (HCC) typically develops as a consequence of liver cirrhosis, but HCC epidemiology has evolved drastically in recent years. Metabolic dysfunction-associated steatotic liver disease (MASLD), including metabolic dysfunction-associated steatohepatitis, has emerged as the most common chronic liver disease worldwide and a leading cause of HCC. A substantial proportion of MASLD-associated HCC...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.